Multidrug resistant gram-negative bacterial blood stream infections in cancer patients - a two years single-center retrospective analysis

被引:0
|
作者
Toelle, D. [1 ]
Bredemann, S. [1 ]
Schwanz, T. [2 ]
Reckmann, A. [1 ]
Theobald, M. [1 ]
Radsak, M. [1 ]
Teschner, D. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Hematol Med Oncol & Pneumol, Univ Med Ctr, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Univ Med Ctr, Mainz, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V430
引用
收藏
页码:146 / 146
页数:1
相关论文
共 50 条
  • [21] Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections
    Matlock, Aaron
    Garcia, Joshua Allan
    Moussavi, Kayvan
    Long, Brit
    Liang, Stephen Yuan-Tung
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (08) : 2231 - 2241
  • [22] Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
    Parsels, Katie A.
    Mastro, Keri A.
    Steele, Jeffrey M.
    Thomas, Stephen J.
    Kufel, Wesley D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1379 - 1391
  • [23] Risk stratification for multidrug-resistant Gram-negative infections in ICU patients
    Burillo, Almudena
    Munoz, Patricia
    Bouza, Emilio
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 626 - 637
  • [24] Anaerobic gram-negative rod bacteremia as a marker of gastrointestinal cancer in Japanese patients: a single-center retrospective study
    Abe, Eiko
    Ishikawa, Kazuhiro
    Onishi, Kazunari
    Mori, Nobuyoshi
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (02)
  • [25] Clinical characteristics and outcomes of patients with multidrug-resistant Gram-negative bacterial infections treated with ceftazidime/avibactam
    Kuang, Huan
    Zhong, Cejun
    Wang, Yuanfang
    Ye, Hui
    Ao, Keping
    Zong, Zhiyong
    Lv, Xiaoju
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 23 : 404 - 407
  • [26] Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022
    Ljungquist, Oskar
    Nazarchuk, Oleksandr
    Kahlmeter, Gunnar
    Andrews, Vigith
    Koithan, Thalea
    Wasserstrom, Lisa
    Dmytriiev, Dmytro
    Fomina, Nadiia
    Bebyk, Vira
    Matuschek, Erika
    Riesbeck, Kristian
    LANCET INFECTIOUS DISEASES, 2023, 23 (07): : 784 - 786
  • [27] A novel cyclic peptide against multidrug-resistant gram-negative bacterial pulmonary infections
    Wannigama, D.
    Hurst, C.
    Monk, P.
    Abe, S.
    Stick, S.
    Kicic, A.
    Chatsuwan, T.
    RESPIROLOGY, 2023, 28 : 140 - 140
  • [28] Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections
    Lovey, Arianne
    Krel, Mila
    Borchardt, Allen
    Brady, Thomas
    Cole, Jason N.
    Do, Quyen-Quyen
    Fortier, Joanne
    Hough, Grayson
    Jiang, Wanlong
    Noncovich, Alain
    Tari, Les
    Zhao, Qiping
    Balkovec, James M.
    Zhao, Yanan
    Perlin, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (11)
  • [29] Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
    Li, Jian
    Nation, Roger L.
    Turnidge, John D.
    Milne, Robert W.
    Coulthard, Kingsley
    Rayner, Craig R.
    Paterson, David L.
    LANCET INFECTIOUS DISEASES, 2006, 6 (09): : 589 - 601
  • [30] Colistin Use for the Treatment of Multi-Drug-Resistant Gram-Negative Severe Infections in ICU Patients: A Single-Center Study
    Rojek, Stanislaw Wojciech
    Wojtowicz, Iga
    Taccone, Fabio Silvio
    Duszynska, Wieslawa
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)